EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessing the Relative Importance of Imaging and Serum Biomarkers in Capturing Disability, Cognitive Impairment, and Clinical Progression in Multiple Sclerosis

Alessandro Cagol iD, Pascal Benkert, Sabine Schaedelin, Mario Ocampo-Pineda, Noemi Montobbio, Po-Jui Lu, Batuhan Ayci, Antonia Wenger, Alfi Aran Shukur, Kornelius Kaim, Lester Melie-Garcia, Matthias Weigel und 6 weitere

Advanced Science · 2026

DOI: 10.1002/advs.202512946 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Alessandro Cagol und 17 weiteren Autor:innen. Beteiligte Einrichtung: Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University…. Hauptthemen laut MEDLINE: Biomarkers, Magnetic Resonance Imaging, Multiple Sclerosis, Cognitive Dysfunction. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The heterogeneity of multiple sclerosis (MS) pathology calls for robust biomarkers to predict disability and progression, particularly progression independent of relapse activity (PIRA). Here, we aimed to identify the most informative MRI and serum biomarkers for predicting clinical outcomes in people with MS (pwMS), including disability severity, cognitive impairment, disease phenotype, and risk of PIRA. We applied a machine learning–based feature selection approach to cross‐sectional and longitudinal data from two independent pwMS cohorts. Cohort 1 (n = 120) included 57 MRI biomarkers, incorporating advanced quantitative MRI (qMRI). Cohort 2 (n = 279) included 35 MRI biomarkers derived from conventional MRI. Both cohorts obtained serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) measurements. Spinal cord atrophy consistently emerged as the strongest predictor of disability severity and predicted PIRA, along with cortical thinning and subcortical atrophy – particularly in deep gray matter. sNfL, sGFAP, and qMRI metrics independently contributed to the prediction of PIRA and progressive disease phenotype. In conclusion, our findings show that spinal cord atrophy and cortical degeneration are the most robust and consistent predictors of MS severity and progression. Serum biomarkers of neuroaxonal and astrocytic damage, together with qMRI‐derived tissue metrics, provide independent and complementary value for outcome prediction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersMagnetic Resonance ImagingMultiple SclerosisCognitive DysfunctionHumansDisease ProgressionFemaleMaleNeurofilament ProteinsAdultCross-Sectional StudiesMiddle AgedAtrophySpinal CordGlial Fibrillary Acidic ProteinLongitudinal StudiesCohort Studies

Stichwörter der Autor:innen

MRIMultiple SclerosisProgression Independent of Relapse ActivityQuantitative MRISerum Glial Fibrillary Acidic ProteinSerum Neurofilament Light ChainSpinal Cord Atrophy

Substanzen

BiomarkersNeurofilament Proteinsneurofilament protein LGlial Fibrillary Acidic Protein

Autor:innen und Institutionen

  • Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, Switzerland.
  • Multiple Sclerosis Centre, Departments of Neurology, Clinical Research and Biomedicine, University Hospital and University Basel, Basel, Switzerland.
  • Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel and University of Basel, Basel, Switzerland.
  • Dipartimento di Scienze della Salute, Università degli Studi di Genova, Genova, Italy.
  • Department of Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey.

ORCID-Profile: Alessandro Cagol, Cristina Granziera

Zitieren

APA

Cagol, A., Benkert, P., Schaedelin, S., Ocampo-Pineda, M., Montobbio, N., Lu, P. J., Ayci, B., Wenger, A., Shukur, A. A., Kaim, K., Melie-Garcia, L., Weigel, M., Signori, A., Calabrese, P., Kappos, L., Sormani, M. P., Kuhle, J., & Granziera, C. (2026). Assessing the Relative Importance of Imaging and Serum Biomarkers in Capturing Disability, Cognitive Impairment, and Clinical Progression in Multiple Sclerosis. Advanced Science. https://doi.org/10.1002/advs.202512946

Vancouver

Cagol A, Benkert P, Schaedelin S, Ocampo-Pineda M, Montobbio N, Lu PJ, et al. Assessing the Relative Importance of Imaging and Serum Biomarkers in Capturing Disability, Cognitive Impairment, and Clinical Progression in Multiple Sclerosis. Advanced Science. 2026. doi:10.1002/advs.202512946

BibTeX
@article{Cagol2026,
  author = {Cagol, Alessandro and Benkert, Pascal and Schaedelin, Sabine and Ocampo-Pineda, Mario and Montobbio, Noemi and Lu, Po-Jui and Ayci, Batuhan and Wenger, Antonia and Shukur, Alfi Aran and Kaim, Kornelius and Melie-Garcia, Lester and Weigel, Matthias and Signori, Alessio and Calabrese, Pasquale and Kappos, Ludwig and Sormani, Maria Pia and Kuhle, Jens and Granziera, Cristina},
  title = {Assessing the Relative Importance of Imaging and Serum Biomarkers in Capturing Disability, Cognitive Impairment, and Clinical Progression in Multiple Sclerosis},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.202512946}
}
Kostenlos starten →